Literature DB >> 29765826

Rates and Locations of Regional Metastases in Sinonasal Malignancies: The Mayo Clinic Experience.

Brandon W Peck1, Kathryn M Van Abel1, Eric J Moore1, Daniel L Price1.   

Abstract

Objectives  The objective of this study was to identify factors that may influence the rate and location of regional metastasis in sinonasal malignancies (SNMs). Design  This is a retrospective review. Setting  This study was set at the single-institution tertiary referral center. Participants  A total of 299 patients were treated for SNMs from 1994 to 2014. Main Outcome Measures  The main outcome measures were incidence and distribution of regional metastases. Results  Several histologic subtypes were treated, with squamous cell carcinoma (28.4%), esthesioneuroblastoma (18.1%), and mucosal melanoma (12.4%) being the most common. Of the 299 patients, 59 (19.7%) developed a regional metastasis, either at presentation or during follow-up. Higher cumulative incidence of regional metastases was significantly associated with histologic type ( p ≤0.001) and invasion of the dura ( p  = 0.005), infratemporal fossa ( p  = 0.036), orbit ( p  = 0.020), or palate ( p  = 0.016). Ipsilateral level II lymph nodes were the most commonly involved nodes. Contralateral regional metastases were associated with higher risk histologic types ( p  = 0.005) and dural invasion ( p  = 0.008). Parotid metastases were associated with invasion of the facial soft tissue ( p  = 0.028), and retropharyngeal metastases were associated with invasion of the pterygoid plates and musculature ( p  = 0.030). Conclusion  Histologic type of SNM appears to be the most important factor in predicting the rate of regional metastases. Histologic type and invasion of certain neighboring structures may help define which lymphatic basins are at highest risk for metastasis.

Entities:  

Keywords:  cancer; metastasis; regional metastases; sinonasal; sinonasal malignancy-

Year:  2017        PMID: 29765826      PMCID: PMC5951705          DOI: 10.1055/s-0037-1607288

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  16 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review.

Authors:  P Dulguerov; M S Jacobsen; A S Allal; W Lehmann; T Calcaterra
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

3.  Squamous cell carcinoma of the nasal cavity: A population-based analysis.

Authors:  Aykut A Unsal; Pariket M Dubal; Tapan D Patel; Alejandro Vazquez; Soly Baredes; James K Liu; Jean Anderson Eloy
Journal:  Laryngoscope       Date:  2015-08-22       Impact factor: 3.325

4.  Squamous cell carcinoma of the maxillary sinus: A population-based analysis.

Authors:  Pariket M Dubal; Amit Bhojwani; Tapan D Patel; Omry Zuckerman; Soly Baredes; James K Liu; Jean Anderson Eloy
Journal:  Laryngoscope       Date:  2015-09-22       Impact factor: 3.325

5.  Clinical significance of neck node metastasis in squamous cell carcinoma of the maxillary antrum.

Authors:  G E Kim; E J Chung; J J Lim; K C Keum; S W Lee; J H Cho; C G Lee; E C Choi
Journal:  Am J Otolaryngol       Date:  1999 Nov-Dec       Impact factor: 1.808

6.  Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment.

Authors:  Giulio Cantù; Gabriella Bimbi; Rosalba Miceli; Luigi Mariani; Sarah Colombo; Stefano Riccio; Massimo Squadrelli; Andrea Battisti; Madia Pompilio; Marco Rossi
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-02

7.  Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.

Authors:  Xiyin Guan; Xiaoshen Wang; Yujie Liu; Chaosu Hu; Guopei Zhu
Journal:  Oral Oncol       Date:  2012-08-09       Impact factor: 5.337

8.  Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.

Authors:  Rahul Dutta; Pariket M Dubal; Peter F Svider; James K Liu; Soly Baredes; Jean Anderson Eloy
Journal:  Laryngoscope       Date:  2015-07-30       Impact factor: 3.325

9.  Malignant tumors of the nasal cavity and paranasal sinuses.

Authors:  Teri S Katz; William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; Douglas B Villaret
Journal:  Head Neck       Date:  2002-09       Impact factor: 3.147

10.  Structural and functional features of central nervous system lymphatic vessels.

Authors:  Antoine Louveau; Igor Smirnov; Timothy J Keyes; Jacob D Eccles; Sherin J Rouhani; J David Peske; Noel C Derecki; David Castle; James W Mandell; Kevin S Lee; Tajie H Harris; Jonathan Kipnis
Journal:  Nature       Date:  2015-06-01       Impact factor: 49.962

View more
  4 in total

1.  Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC).

Authors:  Qian Liu; Yuan Qu; Kai Wang; Runye Wu; Ye Zhang; Xiaodong Huang; Jianghu Zhang; Xuesong Chen; Jingbo Wang; Jianping Xiao; Junlin Yi; Guozhen Xu; Jingwei Luo
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

2.  Leptomeningeal Carcinomatosis from Squamous Cell Carcinoma of the Ethmoid Sinus: A Case Report.

Authors:  Samer G Zammar; Max Hennessy; Joshua Warrick; Neerav Goyal; Brad E Zacharia
Journal:  Cureus       Date:  2019-07-30

3.  Good Visual Outcome Following Corticosteroid Treatment for Compressive Optic Neuropathy Secondary to Sinonasal Carcinoma.

Authors:  Amirah Mohammad Razali; Ayesha Mohd Zain; Wan Haslina Bt Wan Abdul Halim; Norshamsiah Md Din
Journal:  Cureus       Date:  2020-04-18

4.  The Role of Regional Disease and Patterns of Treatment Failure in Primary Sinonasal Malignancies.

Authors:  Christian M Meerwein; Panagiotis Balermpas; Domenic G Vital; Martina A Broglie; Michael B Soyka; David Holzmann
Journal:  Am J Rhinol Allergy       Date:  2021-07-22       Impact factor: 2.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.